People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Enterin, Inc. | — | Biotechnology | Series B | $50.7M | $47.3M | 2021 |
Katherine A Wolf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katherine A Wolf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Denise Barbut | 1 | 9 |
| Mark A. Finn | 1 | 3 |
| Michael Zasloff | 1 | 2 |
| Richard Propper | 1 | 2 |
| Barry A Miller | 1 | 2 |
| Jay A Brammer | 1 | 2 |
| David McCullough | 1 | 2 |
| Nancy A. Ness | 1 | 2 |
| Mark Finn | 1 | 2 |
| Richard A Larson | 1 | 1 |
| Roger A Mills | 1 | 1 |
| William A Kinney | 1 | 1 |
| Richard A Propper | 1 | 1 |
| Denise A Barbut | 1 | 1 |
| David A Vogel | 1 | 1 |
| David A McCullough | 1 | 1 |
| Jay Brammer | 1 | 1 |
| Stuart Barlow | 1 | 1 |
| Don A Munoz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.